Scholarlink

Introduction <p>The expression and/or activity of sirtuins (SIRTs), nicotinamide adenine dinucleotide (NAD<sup>+</sup>)-dependent enzymes that regulate cellular energy metabolism, is decreased in obesity and in aging in animal models. However, the impact of obesity compared to aging on NAD<sup>+</sup>/SIRT expression in human white adipose tissue (AT) remains unexplored. Here, we unravel the effects of obesity and aging on the expression of NAD<sup>+</sup>/SIRT pathway and their associated genes in subcutaneous AT of identical twin pairs discordant for weight, in two age groups.</p> Methods <p>We examined 49 monozygotic twin pairs discordant for BMI (within-pair difference in BMI ≥ 2.5 kg/m<sup>2</sup>, with mean BMIs 25.6 kg/m<sup>2</sup> (leaner) and 30.8 kg/m<sup>2</sup> (heavier), aged 22–38 and 56–69 years. Detailed phenotyping included body composition, insulin resistance (oral glucose tolerance test) and plasma lipids and inflammation markers. RNA sequencing and DNA methylation analyses in AT identified differentially expressed and methylated NAD<sup>+</sup>/SIRT pathway genes in obesity and aging, with linear mixed models linking gene expression to metabolic features.</p> Results <p>SIRT5 and NAD<sup>+</sup> biosynthetic genes were downregulated in AT in both obesity and aging. Obesity was characterized by downregulation of AT NAD<sup>+</sup>/SIRT genes, and NAD<sup>+</sup>/SIRT regulated mitochondrial oxidative metabolism genes, and upregulation of stress markers. Aging showed a downregulation of AT PARPs, except upregulation for PARP1, a main consumer of NAD<sup>+</sup>. Mitochondrial metabolism and glycolysis genes were linked to corresponding DNA methylation. Downregulation of NAD<sup>+</sup>/SIRT genes correlated with increased adiposity, insulin resistance, inflammation, and dyslipidemia.</p> Conclusion <p>Impaired NAD<sup>+</sup>/SIRT metabolism in AT may play a key role in obesity- and aging-related diseases. Both conditions are characterized by downregulation of NAD<sup>+</sup>/SIRT pathway genes, correlating with increased adiposity, insulin resistance, inflammation, and dyslipidemia. Obesity uniquely disrupts expression of NAD<sup>+</sup>/SIRT regulated mitochondrial genes, while aging is characterized by altered PARP expression, particularly increased PARP1, likely exacerbating metabolic dysfunction in AT.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The effect of obesity and aging on NAD+/Sirtuin metabolism transcription and DNA methylation in subcutaneous adipose tissue of monozygotic twin pairs discordant for BMI

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月5日

查看全文
  • Helena A. K. Lapatto,
  • Birgitta W. van der Kolk,
  • Maheswary Muniandy,
  • Sini Heinonen,
  • Aino Heikkinen,
  • Marcus Alvarez,
  • Seung Hyuk T. Lee,
  • Riikka Jokinen,
  • Jesper Lundbom,
  • Juho Kuula,
  • Antti Hakkarainen,
  • Per-Henrik Groop,
  • Jaakko Kaprio,
  • Taru Tukiainen,
  • Miina Ollikainen,
  • Päivi Pajukanta,
  • Eija Pirinen,
  • Kirsi H. Pietiläinen

摘要

Introduction

The expression and/or activity of sirtuins (SIRTs), nicotinamide adenine dinucleotide (NAD+)-dependent enzymes that regulate cellular energy metabolism, is decreased in obesity and in aging in animal models. However, the impact of obesity compared to aging on NAD+/SIRT expression in human white adipose tissue (AT) remains unexplored. Here, we unravel the effects of obesity and aging on the expression of NAD+/SIRT pathway and their associated genes in subcutaneous AT of identical twin pairs discordant for weight, in two age groups.

Methods

We examined 49 monozygotic twin pairs discordant for BMI (within-pair difference in BMI ≥ 2.5 kg/m2, with mean BMIs 25.6 kg/m2 (leaner) and 30.8 kg/m2 (heavier), aged 22–38 and 56–69 years. Detailed phenotyping included body composition, insulin resistance (oral glucose tolerance test) and plasma lipids and inflammation markers. RNA sequencing and DNA methylation analyses in AT identified differentially expressed and methylated NAD+/SIRT pathway genes in obesity and aging, with linear mixed models linking gene expression to metabolic features.

Results

SIRT5 and NAD+ biosynthetic genes were downregulated in AT in both obesity and aging. Obesity was characterized by downregulation of AT NAD+/SIRT genes, and NAD+/SIRT regulated mitochondrial oxidative metabolism genes, and upregulation of stress markers. Aging showed a downregulation of AT PARPs, except upregulation for PARP1, a main consumer of NAD+. Mitochondrial metabolism and glycolysis genes were linked to corresponding DNA methylation. Downregulation of NAD+/SIRT genes correlated with increased adiposity, insulin resistance, inflammation, and dyslipidemia.

Conclusion

Impaired NAD+/SIRT metabolism in AT may play a key role in obesity- and aging-related diseases. Both conditions are characterized by downregulation of NAD+/SIRT pathway genes, correlating with increased adiposity, insulin resistance, inflammation, and dyslipidemia. Obesity uniquely disrupts expression of NAD+/SIRT regulated mitochondrial genes, while aging is characterized by altered PARP expression, particularly increased PARP1, likely exacerbating metabolic dysfunction in AT.